Fidji Simo, the former OpenAI executive who cofounded the biomedical startup ChronicleBio, said she believes AI can eventually cure all diseases, but smarter models alone won’t get us there. In an X post on Monday, Simo responded to Anthropic CEO Dario Amodei, who wrote over the weekend that AI companies need to deliver concrete breakthroughs
When Fidji Simo announced she was leavin g her role as one of the most senior members of OpenAI’s leadership team after a seven year battle with her chronic illness, Postural Orthostatic Tachycardia Syndrome, or POTS, the news felt unexpectedly personal. My little cousin has POTS, and it’s been devastating to witness. Simo’s post said
The CEO of OpenAI Fidji Simo, in charge of AGI implementation, will leave her full-time position at the company and become a part-time consultant. The move comes after Simo took a month-long medical leave due to a worsening neuroimmune condition. “Three months ago, I had to take medical leave after a serious exacerbation of a
Fidji Simo, CEO of OpenAI’s AGI Deployment and the company’s second executive, will leave her full-time role following a three-month medical leave, she said in a note in X on Thursday. “Three months ago, I had to take medical leave after a serious exacerbation of a chronic illness I’ve lived with for seven years,” he
Fidji Simo, OpenAI’s No. 2 executive, is leaving her full-time position, the Wall Street Journal reports. In a note to staff Thursday, Simo said his current medical leave has proven longer and more difficult than expected, and he will instead transition to a part-time advisory role. Simo joined OpenAI’s board of directors in 2024 and